Matches in UGent Biblio for { <https://biblio.ugent.be/publication/1055721#aggregation> ?p ?o. }
Showing items 1 to 34 of
34
with 100 items per page.
- aggregation classification "A4".
- aggregation creator B175660.
- aggregation creator B175661.
- aggregation creator B175662.
- aggregation creator B175663.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2011".
- aggregation format "application/pdf".
- aggregation hasFormat 1055721.bibtex.
- aggregation hasFormat 1055721.csv.
- aggregation hasFormat 1055721.dc.
- aggregation hasFormat 1055721.didl.
- aggregation hasFormat 1055721.doc.
- aggregation hasFormat 1055721.json.
- aggregation hasFormat 1055721.mets.
- aggregation hasFormat 1055721.mods.
- aggregation hasFormat 1055721.rdf.
- aggregation hasFormat 1055721.ris.
- aggregation hasFormat 1055721.txt.
- aggregation hasFormat 1055721.xls.
- aggregation hasFormat 1055721.yaml.
- aggregation language "eng".
- aggregation publisher "Deutsches Elektronen-Synchrotron (DESY). Hamburger Synchrotronstrahlungslabor (HASYLAB)".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "SR 2D micro-XRF imaging on entire rat thin sections in view of a pharmacokinetic study of a new bromine containing drug agains tuberculosis".
- aggregation abstract "Tuberculosis (TB) is a common and often deadly infectious disease caused by various strains of mycobacteria, usually Mycobacterium tuberculosis in humans. Because of population growth, the absolute number of new cases is still increasing. Multi-drug-resistant tuberculosis (MDR-TB) is defined as resistance to the two most effective first-line TB drugs and is a public health issue in many developing countries, as treatment is longer and requires more expensive drugs. Recently, a new experimental diarylquinoline anti-tuberculosis drug was discovered at Janssen Pharmaceutica, referred to as TMC207 and shown in Fig. 1. Before TMC207 can be made commercially available, one of the necessary investigations is a thorough pharmacokinetic study to investigate its absorption, distribution, metabolism and excretion (ADME).".
- aggregation authorList BK429985.
- aggregation aggregates 1055725.
- aggregation isDescribedBy 1055721.
- aggregation similarTo LU-1055721.